Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

3.70
Delayed Data
As of Apr 29
 -0.10 / -2.63%
Today’s Change
2.28
Today|||52-Week Range
11.65
-20.26%
Year-to-Date
No recent news for Anthera Pharmaceuticals Inc.

Today’s Trading

Previous close3.80
Today’s open3.77
Day’s range3.60 - 3.86
Volume503,256
Average volume (3 months)642,571
Market cap$152.0M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+27.21%
Earnings growth (this year)-24.76%
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales51.91
Price/Book3.83

Competitors

 Today’s
change
Today’s
% change
TBRATobira Therapeutics ...-0.25-3.08%
NWBONorthwest Biotherape...-0.11-7.28%
ACRXAcelRx Pharmaceutica...+0.06+1.81%
NEOSNeos Therapeutics In...-0.26-2.79%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$3.2M
Annual profit (last year)-$35.2M
Net profit margin-1,105.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Paul F. Truex
President &
Chief Operating Officer
John Craig Thompson
Corporate headquarters
Hayward, California

Forecasts

Partner Offers

Search for Jobs